Solicitous Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 22-12-2024
- Paid Up Capital ₹ 0.10 M
as on 22-12-2024
- Company Age 11 Year, 2 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 M
as on 22-12-2024
- Revenue 13.69%
(FY 2020)
- Profit 36.78%
(FY 2020)
- Ebitda 22.71%
(FY 2020)
- Net Worth 18.57%
(FY 2020)
- Total Assets 7.17%
(FY 2020)
About Solicitous Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 M.
Shakeel Math, Sajad Pathan, Zameeruddin, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100DL2013PTC262658
- Company No.
262658
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Dec 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Solicitous Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shakeel Math  | Director | 24-Dec-2013 | Current |
| Sajad Pathan | Director | 24-Dec-2013 | Current |
| Zameeruddin | Director | 24-Dec-2013 | Current |
| Mohammad Naieem | Director | 06-May-2015 | Current |
Financial Performance of Solicitous Pharmaceuticals.
Solicitous Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 13.69% increase. The company also saw a substantial improvement in profitability, with a 36.78% increase in profit. The company's net worth Soared by an impressive increase of 18.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Solicitous Pharmaceuticals?
In 2020, Solicitous Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Dec 2019 | ₹1.50 M | Open |
How Many Employees Work at Solicitous Pharmaceuticals?
Solicitous Pharmaceuticals has a workforce of 36 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Solicitous Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solicitous Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
